FAST NEWS: Hillhouse invests $22 million in Legend Biotech
The latest: Genscript Biotech Corp. (1548.HK) announced on Sunday that its New York-listed subsidiary Legend Biotech Corp. (LEGN.US) has sold 692,782 shares through a private placement to LGN Holdings Ltd.,…
Recent Articles
RELATED ARTICLES
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK -
Sunshine tries out asset leasing as insurance demand cools
6963.HK 3396.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
BRIEF: Tencent invests in major new Ubisoft unit
0700.HK UBI.PA
-
ZG Group set to forge Hong Kong’s second De-SPAC listing
2572.HK
